Introduction
============

Multi-cellular organisms have evolved multiple mechanisms to respond to decreased oxygen levels (hypoxia) \[[@b1]\]. The three important physiological responses to hypoxia are: pulmonary vascular constriction to shunt blood to better oxygenated regions of the lung; neurotransmitter release by the carotid body to increase breathing and production of the hormone erythropoietin (EPO) to enhance red blood cell proliferation to increase the haemoglobin concentration in the blood \[[@b2]\]. Hypoxia is observed in many diseases such as ischemia and cancer \[[@b3]\]. Although physiological responses to hypoxia at the tissue level have been appreciated for decades, the molecular and cellular biology of hypoxia have only been elucidated in the past 15 years. The discovery of the transcription factor hypoxia inducible factor 1 (HIF-1) led to understanding the underlying molecular responses to hypoxia \[[@b4]\]. HIF-1 was discovered as a nuclear factor bound to a cis-acting hypoxia response element (HRE) in the 3′ flanking region of the EPO gene during hypoxia. HIF-1 is a heterodimer of two basic helix loop-helix/PAS proteins, HIF-1α and the aryl hydrocarbon nuclear trans-locator (ARNT or HIF-1β). HIF-1α protein is only detectable under hypoxic conditions, while HIF-1β subunit is constitutively stable \[[@b5]\]. Subsequently, HIF-2α and HIF-3α were discovered, which show similar regulation in response to hypoxia \[[@b6], [@b7]\]. The regulation and biological consequences of HIF activation have been a major focus of hypoxia research. In the past decade, a major role for the mitochondria in the regulation of HIFs and vice versa has been elucidated. This article reviews how coordinated signalling between HIFs and the mitochondria regulate the cellular response to hypoxia.

Oxidative phosphorylation
=========================

Historically, mitochondria have been viewed primarily as consumers of oxygen in order to generate ATP, *i.e.* oxidative phosphorylation. Mitochondrial oxygen consumption is initiated when reducing equivalents generated primarily as NADH and FADH2 from the TCA cycle provide electrons to the mitochondrial electron transport chain complexes I and II, respectively. Complexes I and II provide two electrons to ubiquinone (Q) resulting ubiquinol (QH2, reduced ubiquinone). Ubiquinol transfers its electrons to complex III (bc1 complex), which donates its electrons to cytochrome c. Reduced cytochrome c can transfer its electrons to complex IV (cytochrome c oxidase). Subsequently, complex IV transfers the electrons to molecular oxygen. The electron transport chain is located in the inner mitochondrial membrane. Cytochrome c is not membrane bound. The movement of electrons through the electron transport chain is coupled to proton translocation from the mitochondrial matrix to the inner mitochondrial membrane space ([Fig. 1](#fig01){ref-type="fig"}). The pumping of protons across the inner mitochondrial membrane generates an electrochemical gradient of protons consisting of pH gradient and a membrane potential. These protons return down their gradient either through a proton leak or the ATP synthase (complex V). The ATP synthase couples the transport across the membrane to the synthesis of ATP from ADP to Pi. The phosphate for the phosphorylation is transported into the mitochondria by the phosphate carrier, and the ATP is exported to the cytosol in exchange for ADP by the adenine nucleotide carrier located in the inner mitochondrial membrane.

![Overview of oxidative phosphorylation. Oxidative phosphorylation is the flow of electrons from NADH and FADH2 to O~2~ through the mitochondrial electron transport chain resulting in pumping of protons across the inner mitochondrial membrane into the intermembrane space. This creates a proton-motive force which is utilized to generate ATP through the ATP synthase.](jcmm0014-0795-f1){#fig01}

Hypoxic activation of HIFs
==========================

A major breakthrough in our understanding of the regulation of HIFs came from studies demonstrating that complexes containing the tumour suppressor von Hippel-Landau protein (pVHL) serves as an E3 ubiquitin ligase for the degradation of HIF-α protein during normoxia \[[@b8]\]. Subsequently several groups of investigators demonstrated that HIF-α protein is hydroxylated at proline residues by prolyl hydroxylases (PHDs) under normoxia to allow pVHL to interact with HIF-α protein for ubiquitin targeted degradation \[[@b9]--[@b12]\]. HIF-α protein is also hydroxylated at an asparagine residue by the asparaginyl hydroxylase factor inhibiting HIF-1 (FIH) under normoxia to prevent interactions with co-activators such as p300 and aberrant transcriptional activation \[[@b13], [@b14]\]. Hypoxia suppresses the hydroxylation of proline and asparagine residues, thereby allowing full HIF mediated transcriptional activation.

Mitochondria regulate HIFs
==========================

The hydroxylation of HIF-α protein by PHDs is inherently oxygen dependent since the oxygen atom of the hydroxy group is derived from molecular oxygen. In addition, prolyl hydroxylation requires the mitochondrial TCA cycle intermediate 2-oxoglutarate and iron as cofactors. 2-oxoglutarate is required because the hydroxylation reaction is coupled to the decarboxylation of 2-oxoglutarate to succinate, which accepts the other oxygen atom from molecular oxygen. Since the hydroxylation reaction requires oxygen, it has been widely speculated that PHDs act as the direct oxygen sensors for hypoxic activation of HIFs \[[@b15]\]. Clearly, in the absence of oxygen or iron, HIF-α would not undergo proline hydroxylation and subsequent pVHL mediated ubiquitin-targeted degradation. Thus, the PHDs would be sensors under anoxia. However, it is not clear whether the PHDs would intrinsically be inhibited at higher levels of oxygen (1--2% O~2~), which have also been shown to activate HIFs. These higher levels of oxygen are more likely to be encountered in physiological conditions associated with tissue hypoxia, for example cancer. Recombinant PHDs have a Km close to ambient air in vitro indicating that the PHDs are decreasing their enzymatic activity throughout the physiological range of PO~2~\[[@b16]\]. Therefore, if the PHDs were in fact the direct oxygen sensors, one would predict a continuous increase in the accumulation of HIF-α protein as oxygen levels fall from 21% O~2~ to 0% O~2~. In fact, the HIF-1α protein begins to accumulate around 5% O~2~ and its concentration increases as the oxygen levels approach anoxia \[[@b17]\]. It is therefore likely that a variety of inputs regulate PHD activity during hypoxia in addition to oxygen concentration \[[@b18]\]. Emerging evidence indicates that the mitochondrial electron transports chain generated reactive oxygen species (ROS) and oxygen consumption regulates hydroxylation of the HIF-α protein during hypoxia \[[@b19]\]. In the next section, we discuss how mitochondrial respiration, ROS and TCA cycle metabolites regulate HIF-α hydroxylation.

Mitochondrial ROS regulates HIFs
--------------------------------

During mitochondrial respiration under normal oxygen conditions, O~2~ is chemically reduced to water by the transfer of four electrons at cytochrome oxidase. The resulting free energy change is conserved in the form of ATP synthesis. It has been estimated that 2--3% of the O~2~ consumed by mitochondria is incompletely reduced, yielding superoxide \[[@b20]\]. Superoxide can be generated at complexes I, II and III of the mitochondrial electron transport chain ([Fig. 2](#fig02){ref-type="fig"}) \[[@b21]\]. Complexes I and II release superoxide into the mitochondrial matrix while complex III can release superoxide into either the mitochondrial intermembrane space or mitochondrial matrix \[[@b22]\]. Complex III generates superoxide during the Q-cycle, which is initiated by the transfer of two electrons to ubiquinone from complex I or complex II resulting in the reduction of ubiquinone to ubiquinol. Subsequently, ubiquinol oxidation requires donation of two electrons: the first electron transfer is to the Rieske iron--sulphur protein (RISP) and cytochrome c1 resulting in the oxidation of ubiquinol to ubisemiquinone at the Qo site of complex III. The second electron is transferred from ubisemiquinone to cytochrome b resulting in the oxidation of ubisemiquinone to ubiquinone. Ubisemiquinone created at the Qo site of complex III is able to donate an electron to oxygen to generate superoxide \[[@b23], [@b24]\]. The availability of O~2~, the reduction state of the electron carriers and the mitochondrial membrane potential determine the ability of electron transport chain to generate superoxide \[[@b25]\].

![Mitochondrial electron transport chain generates superoxide. Complexes I, II and III generate superoxide into the mitochondrial matrix. Complex III can also release superoxide into the intermembrane space. Complex IV does not generate superoxide. Complex III generates superoxide through the Ubiquinone (Q) cycle.](jcmm0014-0795-f2){#fig02}

We have proposed a model in which the increased generation of ROS at complex III of the mitochondrial electron transport chain is required for HIF-1α protein stabilization during hypoxia \[[@b19]\]. The earliest evidence in support of this model was the observation hypoxia paradoxically increases ROS generation \[[@b26], [@b27]\]. Furthermore, cells depleted of their mitochondrial DNA (ρ° cells) were not able to elicit hypoxia induced increase in ROS generation and HIF-1α protein accumulation \[[@b27], [@b28]\]. The overexpression of catalase abolished the HIF-1α protein accumulation in response to hypoxia \[[@b28]\]. Hydrogen peroxide was able to stabilize HIF-1α protein levels under normoxic conditions in both wild-type and ρ° cells28. These initial observations were corroborated by various investigators \[[@b29], [@b30]\]. Genetic evidence to support a role for the hypoxic increase in ROS in the activation of HIFs came from the observation that cells lacking cytochrome *c* fail to stabilize HIF-1α or HIF-2α protein during hypoxia31. Depleting the complex III RISP using shRNAs also prevented hypoxic HIF-1α protein stabilization \[[@b32], [@b33]\]. The evidence that ROS generated at the Qo site of complex III stabilize HIF-1α protein during hypoxia comes from the observation that cells harbouring a deletion of the cytochrome *b* gene are able to stabilize HIF-1α during hypoxia34. Cells deficient in the cytochrome *b* gene are respiratory deficient but are still capable of generating ROS at the Qo site of complex III \[[@b34]\]. Depleting RISP in these cytochrome *b*-deficient cells with shRNAs abolished ROS generation and the hypoxic stabilization of HIF-1α protein. Collectively these experiments demonstrate that the production of ROS at the Qo site of mitochondrial complex III is crucial for the hypoxic stabilization of HIF-α independent of mitochondrial oxygen consumption. Whether hypoxia increases ROS generation has remained a point of contention. Initial studies relied on using oxidant sensitive dyes such as DCFH to monitor ROS production during hypoxia. These dyes have limitations with respect to sensitivity, specificity and photoactivation \[[@b35]\]. More recently, a mitochondrially localized FRET based redox probe and a mitochondrially localized ratiometric redox sensitive green fluorescent protein (GFP) probe have been used to confirm that hypoxia increases mitochondrial derived ROS production \[[@b33], [@b36]\]. The levels of ROS generated during hypoxia appear to be substantially lower than those that induce senescence or apoptosis as assessed using a mitochondrially targeted redox sensitive GFP probe \[[@b36]\]. How ROS inhibits the hydroxylation of the HIF-1α protein is currently not known. The hydroxylation reaction requires the reduced form of iron (Fe^2+^). It is possible that the hydrogen peroxide produced during hypoxia oxidizes Fe^2+^ to Fe^3+^ ([Fig. 3](#fig03){ref-type="fig"}) \[[@b37]\].

![Mitochondria regulate HIFs. HIFs are hetrodimers between the HIFα proteins and HIF1β protein. HIFα proteins are hydroxylated at two distinct proline residues by PHDs under normoxic conditions. The hydroxylation directs the HIFα proteins for pVHL mediated ubiquitin-dependent degradation. The hydroxylation reaction requires oxygen and 2-oxoglutarate as substrates. Mitochondria can regulate hydroxylation by controlling the availability of oxygen and the TCA cycle intermediate 2-oxolgultrate to the PHDs. Furthermore, under hypoxic conditions, the release of ROS from mitochondrial complex III results in prevention of hydroxylation and stabilization of HIFα proteins. Thus, mitochondria regulate HIFα proteins through ROS, oxygen and 2-oxogluatrate availability.](jcmm0014-0795-f3){#fig03}

Mitochondrial respiration regulates HIFs
----------------------------------------

An alternative explanation for the inability of respiratory deficient cells to stabilize HIF-1α protein during hypoxia is the redistribution of oxygen from mitochondria to the PHDs during hypoxia \[[@b38]\]. In this model, normal levels of oxygen consumption in wild-type cells consuming oxygen would result in lower intracellular oxygen levels than those observed in respiratory deficient cells The lower levels of intracellular oxygen would inhibit the PHDs in wild-type cells compared with respiratory deficient cells, stabilizing HIF proteins. This model is not compatible with the observation that certain respiratory deficient mutants such as cells deficient in cytochrome b are able to stabilize HIF-1α protein. These cells show dramatically reduced levels of oxygen consumption but retain their ability to increase the generation of ROS during hypoxia from the Qo site of complex III \[[@b34]\].

Although the redistribution of oxygen from mitochondria to the PHDs during hypoxia is unlikely to be the trigger for hypoxic stabilization of HIF-1α protein, there are examples where high levels of oxygen consumption by the mitochondria would leave the cytosol 'hypoxic'. The overexpression of PGC1α under normoxia can make the cytosol hypoxic through an increase in mitochondrial biogenesis in which stimulates oxygen consumption \[[@b39]\]. This triggers stabilization of the HIF-1α protein. Also in culture conditions where cells under normoxia are confluent or have limited gas exchange cytosolic hypoxia might trigger stabilization of the HIF-1α protein \[[@b40]\].

TCA cycle intermediates regulate HIFs
-------------------------------------

PHDs convert the TCA cycle intermediate 2-oxoglutarate to succinate in order to hydroxylate the HIF-α subunit. Thus, a rise in succinate would prevent hydroxylation by mass action product inhibition. Succinate is normally converted into fumarate within the TCA cycle by succinate dehydrogenase (SDH), a membrane-bound enzyme that is also a component (complex II) of the electron transport chain. SDH is a complex of four different polypeptides (SDHA, SDHB, SDHC and SDHD) and several prosthetic groups that include FAD, non-haem iron (iron--sulphur centres), ubiquinone and haemb \[[@b41]\]. The loss of any of the SDH subunits would be predict to trigger HIF activation since they all should increase succinate levels. Indeed, loss of SDHD elevates HIF-1α protein under normoxia \[[@b42]\]. Mutations in SDHB, SDHC or SDHD gene have been associated with paraganglioma \[[@b43]--[@b45]\]. By contrast, SDHA mutations have not been linked with paraganglioma. Furthermore, RNAi against SDHA does not elevate HIF-1α protein under normoxia \[[@b46]\]. This indicates that the rise in succinate levels due loss of any of the four subunits of SDH not sufficient to increase HIF activation.

Based on the structure and mechanism of complex II it is predicted that mutations in SDH B, C or D would increase ROS generation while mutations in SDHA would not \[[@b41]\]. Indeed, RNAi against SDHA protein does not increase ROS, HIF activation or tumorigenicity \[[@b46]\]. In contrast, RNAi against SDHB protein increases ROS production, HIF activation and tumorigenicity \[[@b46]\]. It is likely that the increase in ROS coupled with an increase in succinate levels cooperate to activate HIFs under normoxia. Another TCA metabolite that regulates HIF activation under normoxia is fumarate \[[@b47]\]. Mutations in the TCA cycle enzyme fumarate hydratase (FH) are associated hereditary leiomyomatosis and renal cell cancer (HLRCC) \[[@b48]\]. Fumarate can inhibit the forward hydroxylation reaction similar to succinate \[[@b49]\]. Recent evidence suggests that loss of FH results in ROS-dependent activation of HIF \[[@b50]\]. Thus, the FH mutation activates HIF by increases both in ROS and fumarate levels.

Hypoxia decreases cellular ATP utilization to diminish mitochondrial respiration
================================================================================

Cells exposed to hypoxia acutely (seconds) do not display a decrease in oxygen consumption \[[@b51]--[@b53]\]. However, as cells are exposed to hypoxia for longer periods (minutes to hours) they display a reversible suppression of oxygen consumption. Cells display this decrease in metabolism at levels of hypoxia (1--3% O~2~) well above those associated with an inhibition of mitochondrial respiration and ATP production secondary to oxygen limitation (typically \<0.5%) \[[@b54]\]. The persistence of mitochondrial respiration in the face of severe hypoxia is explained by the low Km of the cytochrome c oxidase, which is less than 1 μM O~2~\[[@b53]\]. The decrease in oxygen consumption under moderate hypoxia is likely to be an adaptive mechanism to avoid the development of anoxia. During hypoxia, cells that fail to decrease their oxygen consumption are likely to become anoxic faster than cells that can suppress their rate of oxygen consumption \[[@b55]\].

What controls mitochondrial respiration during hypoxia? In their seminal work Chance and Williams proposed that mitochondrial respiration in cells is controlled by cellular ATP utilization. Their model suggested that increased cytoplasmic ATP utilization decreases cytosolic ATP levels and increases cytosolic ADP and Pi levels \[[@b56]\]. The rise in cytosolic ADP levels leads to a rise in mitochondrial ADP *via* the increased activity of the adenine nucleotide carrier. The increased mitochondrial ADP concentration stimulates the ATP synthase to augment the rate of ATP synthesis. The increased ATP synthesis results in a decrease in the mitochondrial membrane potential, which stimulates the respiratory chain to consume oxygen. Aside from cellular ATP utilization, the other factors that control mitochondrial respiration are the NADH supply, the respiratory chain and the degree of proton leak \[[@b57]\]. Metabolic control analysis combines experimental data with mathematical models to estimate the contribution of a given enzyme or pathway to the overall rate of metabolism. Brand and colleagues performed metabolic control analysis on liver cells under normoxia and observed that 15--30% of respiration is controlled by the NADH supply (these include pyruvate supply to the mitochondria, the TCA cycle and any other NADH-supplying reaction); 20% is controlled by the proton leak; and 50% is controlled by ATP utilization by cellular ATPases \[[@b58]\]. Interestingly, the respiratory chain contributes only 0--15% to respiratory control suggesting that the maximal rate of electron transport contributes little to the overall rate of cellular respiration. We did a similar analysis of liver cells under hypoxic conditions and found that although hypoxia decreased oxygen consumption by 50%, the control of respiration had not changed from normoxic conditions \[[@b53]\]. In this study, cellular ATP utilization remained the major factor controlling respiration under hypoxia. Thus, the major reason for the decrease in respiration during hypoxia is due to a decrease in cellular ATP utilization.

A major ATP consumer that hypoxia inhibits is the function of Na/K-ATPase. The activity of the Na/K-ATPase alone can account for 20--70% of the oxygen expenditure of mammalian cells \[[@b59]\]. Na/K-ATPase is a transmembrane protein found in higher eukaryotes that transports Na^+^ and K^+^ across the plasma membrane to maintain ionic gradients \[[@b60]\]. The Na/K-ATPase is a heterodimer composed of α and β subunits \[[@b61]\]. The α subunit is a transmembrane protein that cleaves high-energy phosphate bonds and exchanges intracellular Na^+^ for extracellular K^+^ coupled to the hydrolysis of ATP. The smaller β subunit is a glycosylated transmembrane molecule that controls the heterodimer assembly and insertion into the plasma membrane. Multiple investigators have reported that hypoxia reversibly suppresses Na/K-ATPase activity \[[@b62]--[@b66]\]. The hypoxia-induced decrease of the Na/K-ATPase activity is due to endocytosis of the α subunit from the plasma membrane by PKC ζ. Hypoxia stimulates AMPK α~1~ isoform, which directly phosphorylates PKC ζ at Thr410 to promote Na,K-ATPase endocytosis \[[@b67]\]. The endocytosis of the Na,K-ATPase during hypoxia triggers pVHL-mediated degradation of plasma membrane Na-K-ATPase in an HIF-independent manner \[[@b68]\]. Interestingly, the endocytosis and degradation of the plasma membrane Na-K-ATPase during hypoxia is dependent on mitochondrial generated ROS ([Fig. 4](#fig04){ref-type="fig"}) \[[@b63], [@b69]\].

![Hypoxia regulates mitochondrial respiration. Mitochondrial respiration is regulated by the oxygen, ADP and reducing equivalents (NADH, FADH2 from TCA cycle) availability. Oxygen is limiting for respiration under severe hypoxic conditions (\<0.5% O~2~). Thus under physiological hypoxia (1--3% O~2~) oxygen is not limiting to conduct maximal respiration. The major controller of mitochondrial respiration is ADP availability from the cellular ATP utilization. Hypoxia through mitochondrial ROS also diminishes the activity of Na/K ATPase and mRNA translation. This results in a decrease in cellular ATP utilization and a decrease in ADP availability to mitochondria. Hypoxia also stimulates the release of mitochondrial ROS from complex III to activate HIF-1, which induces the transcription of PDK1. PDK1 negatively regulates pyruvate dehydrogenase, an enzyme that converts pyruvate to acetyl-CoA. Thus, an increase in HIF-1-dependent PDK1 expression results in diminished availability of acetyl-CoA. This also contributes to diminished respiration during hypoxia by decreasing TCA cycle activity.](jcmm0014-0795-f4){#fig04}

The other major ATP consumer that hypoxia inhibits is mRNA translation \[[@b70]\]. The initiation of mRNA translation is regulated by the active eukaryotic initiation factors eIF4F and eIF2 \[[@b71]\]. The mammalian target of rapamycin (mTOR) and pancreatic eIF2α kinase (PERK) are the key regulators of translation during hypoxia \[[@b72], [@b73]\]. In growth-promoting conditions, mTOR sustains translation by phosphorylating the eIF4E-binding proteins (4E-BPs) and ribosomal protein S6 kinases (S6Ks) \[[@b74]\]. The PI3K/Akt signalling up-regulates mTOR activity by alleviating repression of mTOR by the TSC2 complex \[[@b75]\]. Hypoxia (1.5% O~2~) causes rapid (within 15 min.) and reversible hypophosphorylation of mTOR and its effectors 4E-BP1 and S6K \[[@b72]\]. The rapid inhibition of mTOR is HIF independent and occurs through the activation of AMPK76. AMPK phosphorylates TSC2 causing repression of mTOR \[[@b76]\]. Thus, loss of TSC2 effectively suppresses AMPK-induced mTOR inhibition during hypoxia \[[@b77]\].

We recently demonstrated that rapid activation of AMPK during hypoxia is dependent on mitochondrial ROS \[[@b78]\]. The sustained inhibition of mTOR over hours involves the HIF-dependent transcription of REDD1, which suppress mTOR-dependent mRNA translation \[[@b79]\]. The other major contributor to the decrease in mRNA translation during hypoxia is the activation of PERK73. PERK activation results in eIF2α phosphorylation, which inhibits mRNA translation initiation. Mitochondrial ROS have been implicated in the activation of PERK \[[@b80]\].

HIF-1 regulates mitochondrial respiration
=========================================

The regulation of NADH supply by HIF-1 is another regulator of respiration during hypoxia ([Fig. 4](#fig04){ref-type="fig"}). As noted above, the supply of NADH to the respiratory chain accounts for approximately 15--30% of respiratory control. HIF-1 regulates pyruvate supply to mitochondria through activation of pyruvate dehydrogenase kinase 1 (PDK1) \[[@b81], [@b82]\]. PDK1 inactivates pyruvate dehydrogenase, the enzyme responsible for converting pyruvate into acetyl CoA. The HIF-1-induced increase in PDK1 during hypoxia reduces pyruvate conversion to acetyl-CoA resulting in diminished stimulation of the TCA cycle. This decreases the supply of NADH to the respiratory chain. As consequence the HIF-1-dependent decrease in respiration during hypoxia results in an increase in intracellular oxygen tension \[[@b81]\]. In addition, the decrease in HIF-1-dependent respiration during hypoxia might limit the generation of ROS \[[@b82]\]. Thus, the expression of HIF target genes, for example PDK1 might provide a negative feedback loop limiting the supply of NADH and inhibiting further mitochondrial ROS production.

HIF-1 also controls mitochondrial respiration during hypoxia by exchanging subunit 4--1 of cytochrome c oxidase (COX4--1) for the more efficient COX4--2 isoform \[[@b83]\]. Most mammalian cells express COX4--1 isoform under normoxia \[[@b84]\]. Hypoxia through HIF-1 induces COX4--2 mRNA and protein expression \[[@b83]\]. By contrast, COX4--1 mRNA levels do not change in response to alterations in the cellular O~2~ concentration; however, hypoxia increases the degradation of COX4--1 protein levels through HIF-1-dependent expression of LON, a mitochondrial protease. A consequence of COX4--1 switching to COX4--2 enhances the efficiency of the electron flux through the respiratory chain during hypoxia. This enhances ATP generation and decreases hypoxia induced ROS production. The HIF-1-dependent transcriptional effects on COX4 subunits swapping is likely to occur over prolonged hypoxia. To date, most studies indicate that COX activity has minimal effect on respiration. For example, in young adult mice a 95% reduction in skeletal muscle COX activity is not associated with reduced maximal muscle force generation, enhanced fatigue or signs of oxidative damage or apoptosis \[[@b85]\]. This is compatible with the observation in cells that the maximal level of electron transport contributes at most 15% to the control of cellular respiration \[[@b58]\].

HIF-2 regulates mitochondrial oxidative stress
==============================================

Although, HIF-1 and HIF-2 are activated by similar mechanism by hypoxia, they have both overlapping and distinct gene targets. HIF-1 regulates metabolic genes while HIF-2 regulates EPO and the mitochondrial matrix protein superoxide dismutase 2 (SOD2) \[[@b86]--[@b88]\]. Depending on the genetic background, loss of HIF-2 in adult mice results in profound anaemia \[[@b87]\] or multiple organ pathology due to increase in oxidative stress \[[@b88]\]. The livers of HIF2 null mice display increased oxidative stress due to reduced expression of SOD2 as well as frataxin, a chaperone for the oxidant sensitive protein aconitase \[[@b89]\]. The role of HIF-2 regulation of oxidative stress is further supported by the observation that SOD2 levels are markedly increased in VHL null renal cell carcinoma cells \[[@b90]\]. Furthermore, reduction in HIF-2α makes mice more susceptible to oxidative stress induced ischemia-reperfusion injury \[[@b91]\]. It will be interesting whether activation of HIF-2 prevents oxidative stress induced injury in other organs such as brain, lung and heart.

Conclusions
===========

The discovery of the HIFs has provided a molecular explanation for the physiological responses to hypoxia. Furthermore, in appropriate activation of HIFs has been implicated in a variety of pathologies such as cancer. In the past decade, studying the regulation of HIFs has led to an appreciation that mitochondrial metabolism and ROS are essential to regulators of HIFs. Conversely, HIFs have also been shown to regulate mitochondrial metabolism and ROS levels. Since mitochondria are the major consumers of oxygen, it is not surprising that HIFs and mitochondria are inter-connected. The hypoxic response is essential for survival of metazoans thus would have to be linked to mitochondrial metabolism. Understanding the details of mitochondrial regulation of HIFs could pave the way for new therapies to modulate HIF function for HIF associated pathologies.
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